Waldenström Macroglobulinemia

Blood Cancers

Brain Cancer

Metastatic Breast Cancer

Breast Cancer

Childhood Cancers

Anal Cancer

Colorectal Cancer

Esophageal Cancer

Gallbladder Cancer

Gastrointestinal stromal tumor

Liver Cancer

Pancreatic Cancer

Gastrointestinal Cancers

Bladder Cancer

Kidney Cancer

Prostate Cancer

Testicular Cancer

Genitourinary Cancers

Cervical Cancer

Ovarian Cancer

Uterine Cancer

Vulvar Cancer

Gynecologic Cancer

Head & Neck Cancer

Immunotherapy

Acute Myeloid Leukemia

Leukemia

Mesothelioma

Lung Cancer

Follicular Lymphoma

Mantle Cell Lymphoma

Non-Hodgkin Lymphoma

Small Lymphocytic Lymphoma (SLL)

Lymphoma

Myeloma

Cancer of Unknown Primary

Carcinoid Cancer

Neuroendocrine Cancer

Rare Cancers

Sarcoma

Melanoma

Skin Cancer

Thyroid Cancer

News

Cancer Horizons

All News

Blogs

Caregiving

Diet and Exercise

Financial

Psychosocial

Recipes

Sexual Health

Side Effect

Survivorship

Videos

All Videos

CURE Connections

CURE Expert Connections®

CURE Speaking Out

CURE TV

Educated Patient Sound Bites

On Demand: Webinars

Conferences

Conference Coverage 

Conference Listing 

Events

CURE Adventures

CURE Awards

Educated Patient In Person Education

Educated Patient Virtual Education

Resources

Advocacy Groups

Art Gallery

Clinical Trial Corner

Heal®

Partners

Podcasts

Publications

Share Your Story

Subscribe

The non-Hodgkin lymphoma condition center is a comprehensive resource for cancer news & oncologist insights on non-Hodgkin lymphoma. Read more at CURE.

Non-Hodgkin Lymphoma | Oncology & Cancer News | CURE

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of the cancer experience.

About

Advertise / Support

Contact

CancerNetwork.com

TargetedOnc.com

OncLive.com

OncNursingNews.com

Terms & Conditions

Privacy

Do Not Sell My Information

CURE - Oncology & Cancer News for Patients & Caregivers

Facebook

Youtube

Instagram

Spotlight

Breast Cancer Webinar Series

Cancer Type

Bladder

Breast

Kidney

Lung

Ovarian

Prostate

Skin

About CURE

Press Releases

Write for CURE

1rem

Tumor

CURE’s non-Hodgkin lymphoma (NHL) page is an extensive resource of cancer information featuring the latest NHL news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on non-Hodgkin lymphoma.

“Forwards” is the album of Mike Peters’ life.

Peters, the singer and guitarist of Welsh rockers The Alarm, gives fans an inside perspective of his cancer journey on the new album. Arriving via The Twenty First Century Recording Company on June 16, Peters wrote his band’s latest LP while hospitalized for leukemia — often using members of his care team as an unofficial sounding board for the new material.

“I think for a lot of them, they didn't know they were new songs, I was just strumming some chords, playing some things,” Peters told 

®. “And the girls would say, 'Yeah, that's really nice, I'm coming to clean the room again.' Even the medical staff, I'd be playing, I'd put the guitar away when the medical team came in, and nobody said, 'You shouldn't be doing that.' But I would start saying to the doctor, 'Look, I'm a musician, this is my life, I've got to get back to being able to play guitar, and that's why I'm keeping it going.'”

Peters and The Alarm have found a global following over the last 40-plus years thanks to a sound that’s both grounded and anthemic, music that soars and doesn’t pull punches.

“Forwards” is filled with classic Alarm momentum, Peters’ signature propulsion with a purpose. Even the song titles – the title track, “Another Way,” “Transition,” “New Standards” and the hard-hitting single “Next” — seem to will a bright future into existence one composition at a time.

“(The medical staff) kept saying, 'Look Mike, your life's gonna be very different when we get on top of this,' and they wouldn't really say when getting on top of it was or even if getting on top of it was it was a reality,” Peters said.

The songs were Peters’ personal affirmations at a time when, he said, he was receiving few firm answers from his care team.

“People don't like to give out hope to patients, because it can become false hopes, and they don't like to give out ideas of outcomes, because outcomes might not happen, you know,” he said. “And so, there was a lot of reading between the lines, I think, (which) has to go on for patients now.”

One such instance of reading between the lines led Peters to consult, in his words, “Dr. Google,” and suspect that he was being tested for Richter’s Transformation, also known as Richter’s Syndrome, 

an aggressive lymphoma that’s been shown to develop in as many as one in 10 patients with chronic lymphocyte leukemia (CLL

“I could tell it was a real concern,” Peters said. “Without it being voiced until they knew for certain, they wouldn't tell me about Richter’s Syndrome, and they wouldn't say it's not. It was just unspoken, but I knew the testing was going on.”

Peters was negative for Richter’s — but that ambiguity, he said, made his treatment situation scary.

“I thought, 'Well, if it becomes that then I might not come out of this place,'” Peters said. “And so that plays on your mind quite a lot. And you try to be positive about it all and suppress those darker thoughts. But they come out in the music, they just do. And I think your optimism comes out stronger than your pessimism, for me it does anyway.”

‘My doctors have always warned me about pneumonia.’

Peters received a diagnosis of non-Hodgkin’s lymphoma in 1995, then chronic lymphocytic leukemia in 2005, which relapsed in 2015.

Peters — who, with The Alarm, has released 23 studio albums, sold more than 5 million albums and charted 17 Top 50 singles in the United Kingdom — has balanced cancer care and his music career for decades, touring and recording regularly both with The Alarm and as a solo artist.

Jules Peters, Mike’s wife and the keyboard player for The Alarm, is a breast cancer survivor who received her diagnosis during the filming of the 2017 BBC documentary “Mike and Jules: We Still Have Time.” A second documentary, “Jules Peters: My Cancer Journey,” followed in 2018.

Mike and Jules have continued to support the cancer community with the Love Hope Strength foundation, which works to expand the marrow registry, and by converting a Welsh chapel into a retreat for those impacted by cancer.

Mike’s leukemia experience continued in the fall of 2022, with a case of post-tour pneumonia.

“As a leukemia survivor with a compromised immune system, my doctors have always warned me about pneumonia,” Peters said. “And they'd always told me off, if they came to a gig and saw me jumping into the audience or something, 'You shouldn't be doing that.' So when I got pneumonia, I was quite shocked, because it was out of the blue. And I was supposed to rest. The doctors told me I had to stop touring and doing all that, and the only cure for it was to rest.”

Peters did what comes naturally to him — he picked up his guitar.

“I thought, ‘That's one thing I can do and rest, I don't think you can tire yourself out playing the guitar necessarily,’” he said. “And so that got me into the habit of playing guitar on a daily basis, more than I've ever done before, really.”

But the pneumonia didn’t clear up, and testing revealed his leukemia “was starting to go in a different direction and rear its (head), start to fight back against me, I stopped being able to ingest the drugs that had been working to a point, I started to reject all those,” he said.


At Jules’ insistence, doctors admitted him to the hospital. What they found was dire.

“My lungs were full of blood,” Peters said. “The leukemia was out of control. And my blood count was going up close 200 on the white count. And so, they said, 'Look, we're gonna have to put you in hospital while we carry out the tests to find what's really going on,’ and they had to sort of treat the pneumonia and the lungs first before they could get to the leukemia.

“And then they said to me, 'Right, you're going to be in here for a few months.' … I had to lie on my side for weeks, because I had a drain coming out of my back. At times I was allowed to sit up — when they took me off the IV I was allowed to sit up — and I thought, 'I wish I could have my guitar.'”

Jules brought his guitar and Mike started playing, quietly at first, but soon his work caught on with his fellow patients and staff during his two-month hospital stay.


“I wasn't dissuaded from playing the guitar, I was encouraged,” he said. “And then, all of a sudden, new songs started to arrive because that's what happens. And I was in this situation where I wasn't sure what was going on. I wasn't sure what was gonna happen next. I wasn't sure if I was going to go to the next world or get to the next chapter in my life.

Peters and The Alarm are returning to the road in support of “Forwards,” with American dates scheduled for the Gramercy Theatre in New York City on June 23 and 24.

Peters said he’s currently feeling great. He’s on a daily dose of Venclexta (veneotoclax), taking Rituxan (rituximab) every two weeks and receiving monthly immunoglobin therapy treatments.

“I've been on an eternal game of ‘Donkey Kong,’ because every time I got to the end of a ladder and just running out of the drugs, I can get to the next one and there's a new one,” Peters said. “Yes, I've been really lucky, whereas a lot of people I've been treated with haven't been so lucky. I mean, I It's funny, I'm on (Rituxan) now. But seven, eight years ago I rejected (Rituxan), my body wouldn't accept it anymore and had to go on to different ways of treatment. And now I'm back on it with this (Venclexta) it's allowed me to receive, (Rituxan). So, you know, I've got the best of treatment keeping me alive.”

In this episode of the “Cancer Horizons” podcast, Peters tells CURE® about his cancer journey, the creation of “Forwards” and returning to the North Wales Cancer Centre, the hospital where he was treated to film the music video for “Next.”

For more news on cancer updates, research and education, don’t forget to 

‘Forwards,’ the new album by Mike Peters and the Alarm, was written while he was hospitalized for treatment of chronic lymphocyte leukemia and pneumonia. 

Mike Peters of The Alarm Faces Cancer With Rock Optimism on New Album

There’s no stopping Dr. Dawn Mussallem.

Mussallem — a lifestyle medicine and integrative breast cancer specialist at the Robert and Monica Jacoby Center for Breast Health at the Mayo Clinic in Jacksonville, Florida — is a cancer survivor, a recipient of both bone marrow and heart transplants, a mother and a marathon runner.

Mussallem explained to CURE® how her own life experiences have helped her connect with patients on health journeys of their own.

“Going through what you go through, it really gives you the ability to connect with people,” she said. “It's such a gift, that ability to connect, and really kind of be able to have a good sense or intuition, if you may, of where they're at in their cancer journey, and just to be able to be there with them, and that time of vulnerability. And so, it's given me the ability to have a good pulse on exactly where I need to be with a patient.”

When she was 26 and in the early months of medical school, Mussallem began experiencing shortness of breath and fatigue. One doctor told her she had asthma, another concurred and a third said it was all in her head. A few days later, she collapsed on her way home from class — she was in cardiogenic shock, and her heart wasn’t pumping.

Doctors found a 16-centimeter mass in her chest wrapped around her heart that had collapsed her left lung. She was diagnosed with stage 4, large diffuse B-cell non-Hodgkin’s lymphoma, and was told she had three months to live if she didn’t start treatment immediately, she recounted.

Surgery, chemotherapy and a bone marrow transplant followed. And life continued for her. She began her career in medicine, gave birth to a daughter who’s now 19 and, three weeks later, began experiencing heart failure.

Mussallem spent 18 years in heart failure. During that time, she stayed as active as possible, worked with her patients and volunteered at the National Marathon to Finish Breast Cancer operated by the 

, an organization which financially assists and supports patients with breast cancer and funds breast cancer research.

“I remember working here in the Breast Center with my breast cancer patients and volunteering at the DONNA Marathon because I couldn't run — I couldn't walk it with the heart failure,” Mussallem said. “And I remember just thinking, ‘Oh, my gosh, I would give anything one day to be able to run this. If or when I get a transplant, I'll be good enough to do that.’”

The transplant happened in February of 2021, and exactly one year to the day later, Mussallem crossed the marathon’s finish line.

In this episode of the “Cancer Horizons” podcast, Mussallem talks with CURE® about her DONNA Marathon training experience her connection with her patients and the importance of physical activity for patients during their cancer journey.

“For 18 years, I wanted to do what I did … but I had to hold back because I knew I only had so much to give,” she said. “And now I can just give and give and give because I feel great. I gotta get rid of my energy.”

The DONNA Foundation

Dr. Dawn Mussallem of the Mayo Clinic tells CURE®’s “Cancer Horizons” podcast about how surviving stage 4 non-Hodgkin’s lymphoma and being a heart transplant recipient helps her connect with her patients.

Doctor, Cancer Survivor and Marathoner Goes the Distance for Her Patients: ‘Now I Can Just Give’

When Jeri Davis was diagnosed with non-Hodgkin lymphoma in September 2020 and quickly started treatment, she began writing down her thoughts. She noticed that the fog of “chemo brain” and her determination to remain positive kept her laughing through the process and deepened her connection to her care team.

In this episode of the “CURE® Talks Cancer” podcast, Davis explains how writing down her off-center and amusing thoughts led to the creation of an 

 for other survivors and patients in active treatment.

“I just didn't know that chemotherapy was a place where you could laugh,” said Davis. “It seemed like maybe you should be kind of serene, and sedate and respectful and mindful of others. And then I heard laughter at the nurse's station and I’m like ‘well, wait a minute, maybe I have a wrong impression of this.’ And they're like, ‘no, we'd like to hear you laugh. We like to know there's life here. And we're the ones who want to treat you like you're human, like your home.’”

In this episode of the “CURE® Talks Cancer” podcast, a cancer survivor explains how she took a lighthearted and comedic approach to her cancer treatment process and went on to create a coloring book based on the funny thoughts she had.

Turning Chemotherapy Into Comedy

 Talks Cancer” podcast, we spoke with Dr. Asher Chanan-Khan about the current standards of care for Waldenstrom macroglobulinemia, also known as WM.

WM is a rare, incurable disease. Its current standards of care available consist of Rituxan (rituximab), Imbruvica (ibrutinib) combinations or monotherapy in the first- and second-line setting. However, there are no treatments currently approved for the third line.

Chanan-Khan discussed these options, as well as a novel agent, CLR 131, that is being evaluated in a phase 2 study.

For more news on cancer updates, research and education, don’t forget to

In this episode of the “CURE Talks Cancer” podcast, we spoke with Dr. Asher Chanan-Khan about current standards of care for Waldenstrom macroglobulinemia, as well as a clinical trial looking at a novel therapy.

Treating Waldenstrom’s Macroglobulinemia

Laurie was no stranger to cancer after she faced a bout with stage 3b non-Hodgkin lymphoma back in 1977, but her second diagnosis of breast cancer left her with a very tough decision on how she wanted to move forward with treatment.

After her oncologist recommended she us a diagnostic test, called the Oncotype DX assay, that helps make informed, individualized treatment decisions, Laurie was able to forgo chemotherapy treatment when she received a recurrence score that indicated that she had a relatively low risk of her cancer returning.

This week, we spoke with Laurie about her treatment decisions, and how this diagnostic test gave her what she calls “a piece of her life back.”

Laurie was no stranger to cancer after she faced a bout with stage 3b non-Hodgkin lymphoma back in 1977, but her second diagnosis of breast cancer left her with a very tough decision on how she wanted to move forward with treatment.
 

Handing a Piece of Life Back

Talks Cancer, we spoke with Matt Lashey, creator and CEO of the 

, which is designed to manage cancer symptoms and conditions by keeping track of a patient’s overall well-being to understand how their experiences may be related to feeling better or worse during treatment. 

Matt explains why this app is helpful for patients and their caregivers, and, that at the end of the day, you do have control of your cancer treatment.

In this week’s episode of CURE Talks Cancer, we spoke with Matt Lashey, creator and CEO of the chemoWave app, which is designed to manage cancer symptoms and conditions by keeping track of a patient’s overall well-being to understand how their experiences may be related to feeling better or worse during treatment. 

Navigating the Waves of Cancer Treatment

The actor, 65, received his diagnosis of stage 3 non-Hodgkin lymphoma in October, he said.

‘Full House’ Star Dave Coulier Has Non-Hodgkin Lymphoma

Jylamvo is an oral liquid formulation of methotrexate originally approved in 2022 for adults with acute lymphoblastic leukemia, among other diseases. 

FDA Expands Approval for Jylamvo to Children With Acute Lymphoblastic Leukemia

More frequent immunoglobulin G testing was associated with a decreased risk of severe infections in patients with CLL and non-Hodgkin lymphoma. 

Antibody Testing May Decrease Infection Risk in Blood Cancer Survivors 

Staying positive while receiving cancer treatment for non-Hodgkin lymphoma helped me feel grateful for happy moments. 

My Positive Spin on Receiving Cancer Treatment

My experience with non-Hodgkin lymphoma taught me to be grateful for the people I love and who love me.  

Accepting Cancer With Grace 

In 1998, Marla Briskman was diagnosed with mantle cell lymphoma, a subtype of 

For National Family Caregivers Month, lymphoma caregiver Rickey Briskman explains the importance of caregivers putting themselves first. 

Non-Hodgkin Lymphoma

Latest News